|
1)
FOLFOX-4 stop and go and capecitabine maintenance chemotherapy in
the treatment of metastatic colorectal cancer.
Petrioli R, Paolelli L, Marsili S, Civitelli S, Francini E, Cioppa
T, Roviello F, Nettuno R, Intrivici C, Tanzini G, Lorenzi M,
Francini G.
Oncology.
2006;70(5):345-50. Epub 2006 Dec 15.
2)
Continuous oral capecitabine at fixed dose in patients older than 75
years with metastatic colorectal and gastric cancer: a study of the
Multidisciplinary Oncology Group on Gastrointestinal Tumors.
Petrioli R, Pascucci A, Francini E, Marsili S, Fiaschi AI, Civitelli
S, Tanzini G, Battistelli S, Lorenzi M, Roviello F, Francini G;
Multidisciplinary Oncology Group on Gastrointestinal Tumors.
Anticancer Drugs. 2008 Jan;19(1):91-6.
3)
Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with
colon and gastric cancer: a randomized study of two different
schedules of oxaliplatin.
Petrioli R, Pascucci A, Francini E, Marsili S, Sciandivasci A, Tassi
R, Civitelli S, Tanzini G, Lorenzi M, Francini G.
Cancer Chemother Pharmacol. 2008 Jan;61(1):105-11. Epub 2007
Apr 12.
|